CD8 + T cells and NK cells are key players in the immune response against cancer cells, with CD8 + T cells differentiating into cytotoxic T lymphocytes that eliminate cancer cells, and NK cells playing a crucial role in immune surveillance, with their infiltration in tumor tissues being prognostic in some patient cohorts62,63. The gene discussed is CD8A; the disease is neoplasm.